Biocon launched Gilead Sciences’ Hepatitis C drug – CIMIVIR-L in India
Posted on25 Dec 2015
TagsBiocon, Biocon launched Gilead Sciences' Hepatitis C drug - CIMIVIR-L in India, CIMIVIR-L, Cipla, Gilead Sciences, Hepcvir-L
Comments0
BIopharmaceutical company Biocon on Thursday said it has launched a generic version of Gilead Sciences’ Hepatitis C drug, Harvoni, in India. The... Read More